Clinical Trial Update: Interstitial Lung Disease Research Unit Biobank

View source ↗

Summary

A clinical trial update for an Interstitial Lung Disease Research Unit Biobank at University of Kansas Medical Center; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypersensitivity Pneumonitis
• Idiopathic Pulmonary Fibrosis
• Interstitial Lung Disease
• Pulmonary Fibrosis
• Sarcoidosis

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Interstitial Lung Disease, Sarcoidosis | Status: RECRUITING